Keyphrases
Hazard Ratio
100%
Clinical Outcomes
100%
Clinical Features
100%
Age Groups
100%
Non-valvular Atrial Fibrillation
100%
Oral Anticoagulants
100%
All-cause Mortality
50%
Non-vitamin K Antagonist Oral Anticoagulants
50%
Antithrombotic Therapy
40%
Super-elderly Patient
40%
Vitamin K Antagonists
40%
Clinically Significant
30%
Gastrointestinal Bleeding
30%
Non-majors
30%
Bleeding Events
30%
Major Bleeding
20%
Bleeding Risk
20%
Prognostic Benefit
20%
Clinical Characteristics
10%
China
10%
Older Patients
10%
Ischemic Stroke
10%
Follow-up Time
10%
Stroke Risk
10%
First Occurrence
10%
Mortality Hazard
10%
Super-elderly
10%
Antiplatelet Agents
10%
Major Bleeding Events
10%
85-year-old
10%
Minor Bleeding
10%
CHA2DS2-VASc Score
10%
Macau
10%
Transient Ischemia Attack
10%
Special Administrative Region
10%
HAS-BLED Score
10%
Medicine and Dentistry
Hazard Ratio
100%
Clinical Feature
100%
Atrial Fibrillation
100%
Antithrombotic
100%
Vitamin K Antagonist
90%
Apoplexy
70%
Elderly Patient
40%
All Cause Mortality
40%
Major Bleeding
30%
Gastrointestinal Bleeding
30%
Antithrombotic Therapy
30%
Bleeding
10%
Ischemia
10%
Brain Ischemia
10%
Thromboembolism
10%
Antiplatelet Drug
10%
Cause of Death
10%
CHA2DS2-VASc Score
10%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Feature
100%
Atrial Fibrillation
100%
Anticoagulant Agent
100%
Antivitamin K
100%
Cerebrovascular Accident
77%
All Cause Mortality
44%
Bleeding
33%
Gastrointestinal Hemorrhage
33%
Antithrombotic Therapy
33%
Brain Ischemia
11%
Ischemia
11%
Thromboembolism
11%
Antithrombocytic Agent
11%
Cause of Death
11%
Neuroscience
Antithrombotic
100%
Atrial Fibrillation
100%
Vitamin K Antagonist
75%
Cerebrovascular Accident
58%
Brain Ischemia
8%
Antiplatelet Drug
8%
Ischemia
8%